Aster DM Healthcare's Q3 FY 2025-26 Quarterly Results
- 31 Jan 2026
Result Summary
- Aster DM Healthcare Ltd reported a 1.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 12.1%.
- Its expenses for the quarter were up by 2.8% QoQ and 12.6% YoY.
- The net profit decreased 51.7% QoQ and decreased 8.9% YoY.
- The earnings per share (EPS) of Aster DM Healthcare Ltd stood at 1.02 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 1213.73 | 1225.46 | 1082.80 | -1.0% | 12.1% |
Total Expenses | 1073.64 | 1044.25 | 953.61 | 2.8% | 12.6% |
Profit Before Tax | 111.80 | 180.85 | 105.47 | -38.2% | 6.0% |
Tax | 44.40 | 45.54 | 37.49 | -2.5% | 18.4% |
Profit After Tax | 58.65 | 121.31 | 64.39 | -51.7% | -8.9% |
Earnings Per Share | 1.02 | 2.13 | 1.14 | -52.1% | -10.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Aster DM Healthcare Ltd is a prominent player in the healthcare industry, primarily focused on providing a wide range of healthcare services. The company operates hospitals, clinics, and pharmacies across several countries, known for offering quality medical care and services. Aster DM Healthcare has made significant strides in expanding its footprint, catering to diverse healthcare needs. While specific recent developments are not available, the company is recognized for its commitment to healthcare excellence and innovation.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Aster DM Healthcare Ltd reported total income of ₹1213.73 crores. This represents a decrease of 1.0% from the previous quarter (Q2FY26), where the total income was ₹1225.46 crores. However, when compared to the same quarter in the previous year (Q3FY25), there is a notable increase of 12.1% from ₹1082.80 crores. The year-over-year growth highlights the company's ability to enhance revenue generation amidst changing market conditions.
Profitability
For Q3FY26, Aster DM Healthcare Ltd recorded a Profit Before Tax (PBT) of ₹111.80 crores, reflecting a significant quarter-over-quarter decline of 38.2% from ₹180.85 crores in Q2FY26. Despite this quarterly dip, there was a year-over-year increase of 6.0% from ₹105.47 crores in Q3FY25. After accounting for taxes, the Profit After Tax (PAT) stood at ₹58.65 crores, which is a decline of 51.7% from the previous quarter's ₹121.31 crores and an 8.9% decrease from ₹64.39 crores in the same quarter last year. These figures indicate fluctuations in profitability across different periods.
Operating Metrics
The Earnings Per Share (EPS) for Q3FY26 was reported at ₹1.02, marking a decrease of 52.1% from the previous quarter's ₹2.13 and a 10.5% reduction from ₹1.14 in Q3FY25. Total expenses for the quarter were ₹1073.64 crores, showing a 2.8% increase from ₹1044.25 crores in Q2FY26 and a 12.6% rise from ₹953.61 crores in Q3FY25. The tax expense for the quarter amounted to ₹44.40 crores, slightly lower than the previous quarter's ₹45.54 crores, but higher by 18.4% compared to ₹37.49 crores in Q3FY25. These metrics provide insight into the company's operational performance over recent quarters.